Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1,n(6)-ethenoadenosine 3',5'-monophosphate

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1,n(6)-ethenoadenosine 3',5'-monophosphate in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(1,n(6)-ethenoadenosine 3',5'-monophosphate)
Trials
(1,n(6)-ethenoadenosine 3',5'-monophosphate)
Recent Studies (post-2010) (1,n(6)-ethenoadenosine 3',5'-monophosphate)
9,156187552800

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deussen, A; Pexa, A1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1,n(6)-ethenoadenosine 3',5'-monophosphate

ArticleYear
Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC).
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 372, Issue:2

    Topics: 5'-Nucleotidase; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Lysophosphatidylcholines; Molecular Structure; Phospholipids; Platelet Activating Factor; Sphingosine; Umbilical Veins

2005